These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21979434)

  • 1. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
    Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
    Yamamoto S; Zhong J; Yancey PG; Zuo Y; Linton MF; Fazio S; Yang H; Narita I; Kon V
    Atherosclerosis; 2015 Sep; 242(1):56-64. PubMed ID: 26184694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periaortic adipose tissue-specific activation of the renin-angiotensin system contributes to atherosclerosis development in uninephrectomized apoE-/- mice.
    Kawahito H; Yamada H; Irie D; Kato T; Akakabe Y; Kishida S; Takata H; Wakana N; Ogata T; Ikeda K; Ueyama T; Matoba S; Mori Y; Matsubara H
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H667-75. PubMed ID: 23812390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.
    Suganuma E; Zuo Y; Ayabe N; Ma J; Babaev VR; Linton MF; Fazio S; Ichikawa I; Fogo AB; Kon V
    J Am Soc Nephrol; 2006 Feb; 17(2):433-41. PubMed ID: 16371432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.
    Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B
    Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions.
    Kato T; Kawahito H; Kishida S; Irie D; Wakana N; Kikai M; Takata H; Ogata T; Ueyama T; Matoba S; Yamada H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):936-46. PubMed ID: 25487979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.
    Buzello M; Törnig J; Faulhaber J; Ehmke H; Ritz E; Amann K
    J Am Soc Nephrol; 2003 Feb; 14(2):311-6. PubMed ID: 12538731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of periaortic adipose tissue from angiotensin receptor blocker-treated mice markedly ameliorates atherosclerosis development in apoE-/- mice.
    Irie D; Kawahito H; Wakana N; Kato T; Kishida S; Kikai M; Ogata T; Ikeda K; Ueyama T; Matoba S; Yamada H
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):67-78. PubMed ID: 25324424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.
    Gut N; Piecha G; Pradel A; Geldyyev A; Potemkina A; Ritz E; Regele H; Schmitt CP; Gross-Weissmann ML
    Am J Physiol Renal Physiol; 2013 Aug; 305(3):F277-85. PubMed ID: 23698122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
    Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid Krüppel-like factor 4 deficiency augments atherogenesis in ApoE-/- mice--brief report.
    Sharma N; Lu Y; Zhou G; Liao X; Kapil P; Anand P; Mahabeleshwar GH; Stamler JS; Jain MK
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2836-8. PubMed ID: 23065827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
    Keidar S; Attias J; Heinrich R; Coleman R; Aviram M
    Atherosclerosis; 1999 Oct; 146(2):249-57. PubMed ID: 10532681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.